IP Library › Assignment 005563/0007
Patent Assignment
Reel/Frame 005563/0007

Change of Name Effective on 09/10/1990

Recorded: 1990-11-09 Pages: 9
Assignor
RORER PHARMACEUTICALS INC.
Executed: 1990-09-10
Assignee
Covered Properties (161)
4-Ureido-2-Acyl Phenoxypropanolamine
Patent: 4,034,009 →
Application: 05/533,688 →
Resin Peptides
Patent: 4,062,815 →
Application: 05/615,303 →
Synthesis of Peptides
Patent: 4,301,045 →
Application: 05/792,524 →
Synthesis of Peptides
Patent: 4,217,268 →
Application: 05/926,573 →
Synthesis of Biologically Active Peptides
Patent: 4,239,680 →
Application: 05/927,456 →
Cyclization of Peptides
Patent: 4,212,795 →
Application: 05/960,229 →
Cyclic Amides
Patent: 5,200,416 →
Application: 06/148,083 →
Synthesis of Biologically Active Peptides
Patent: 4,304,692 →
Application: 06/168,102 →
Purification of Calcitonin by Partition Chromatography
Patent: 4,336,187 →
Application: 06/189,812 →
N-Substituted-Amido-Amino Acids
Patent: 4,820,729 →
Application: 06/248,172 →
Pyridyl Alkylene Amidinoureas
Patent: 4,443,456 →
Application: 06/262,808 →
Antihypertensive Compounds
Patent: 4,507,316 →
Application: 06/269,166 →
Leucine 22 Calcitonin
Patent: 4,397,780 →
Application: 06/348,396 →
Synthesis of Peptides
Patent: 4,388,235 →
Application: 06/348,397 →
Glycine - 8 Calcitonin
Patent: 4,401,593 →
Application: 06/348,472 →
Des Asparagine - 3 - Calcitonin
Patent: 4,391,747 →
Application: 06/348,473 →
Purification of Calcitonin by Partition Chromatography
Patent: 4,422,967 →
Application: 06/379,853 →
D-ARGININE24 Calcitonin
Patent: 4,469,632 →
Application: 06/422,998 →
L-TYROSINE21 Calcitonin
Patent: 4,444,681 →
Application: 06/422,999 →
Heterocyclic Amidino Substituted Ureas and Their Pharmaceutical Uses
Patent: 4,707,478 →
Application: 06/425,095 →
Des-SERINE2-Des-TYROSINE22 Calcitonin
Patent: 4,451,395 →
Application: 06/440,113 →
N-Substituted-Amido-Amino Acids
Patent: 4,831,184 →
Application: 06/465,940 →
GLYCINE8-D-ARGININE24 Calcitonin
Patent: 4,414,149 →
Application: 06/471,982 →
Glycine 8-Des-Tyrosine 22 Calcitonin
Patent: 4,497,731 →
Application: 06/481,618 →
Des-Serine 2-Glycine 8 Calcitonin
Patent: 4,495,097 →
Application: 06/481,979 →
Des-SERINE2 or Des-GLYCINE2-LEUCINE22 Calcitonin
Patent: 4,537,716 →
Application: 06/557,778 →
Aryl Substituted Heterocycles for Treating Gastrointestinal Motility Dysfunction
Patent: 4,714,707 →
Application: 06/570,526 →
Heterocyclic Guanidines for Treating Gastrointestinal Motility Dysfunction
Patent: 4,689,335 →
Application: 06/570,585 →
Amidinoureas for Treating Irritable Bowel Syndrome
Patent: 4,701,457 →
Application: 06/570,620 →
(16-Alanine)Calcitonin
Patent: 4,528,132 →
Application: 06/570,701 →
3- and 5-Amino Thiatriazines, and Their Pharmaceutical Uses
Patent: 4,742,055 →
Application: 06/604,988 →
Carboxyalkyl Dipeptide Compounds
Patent: 4,746,676 →
Application: 06/649,797 →
Dry Oil Coated Antacid Process
Patent: 4,605,551 →
Application: 06/676,634 →
Substituted Pheyl Amidinoureas
Patent: 4,704,401 →
Application: 06/678,639 →
Analogs of Calcitonin
Patent: 4,604,238 →
Application: 06/680,195 →
6-(4THIAZOLE)-Carbostyril Compounds,Cardiotonia Compositions Including the Same,and Thier Uses
Patent: 4,721,721 →
Application: 06/683,204 →
(Des-1-Amino, 8-Glycine)Calcitonin
Patent: 4,606,856 →
Application: 06/712,951 →
Antihypertensive Derivatives
Patent: 4,749,698 →
Application: 06/752,695 →
Pyridyl-Pyridazinone and Pyridyl-Pyrazolinone Compounds and Their Use in the Treatment of Congestive Heart Failure
Patent: 4,783,463 →
Application: 06/790,426 →
Bis-Imidazolinoamino Derivatives as Antiallergy Compounds
Patent: 4,889,868 →
Application: 06/809,649 →
3- and 5-(Bicyclic Ether or Bicyclic Alkylene Thioether)Alkylene Amino Thiatriazines, and Their Pharmaceutical Uses
Patent: 4,704,388 →
Application: 06/817,852 →
Angiotensin-Converting Enzyme Inhibitors
Patent: 4,703,037 →
Application: 06/830,422 →
Quinoline Hydroxamines and Their Use as Modulators of Arachidonic Acid Metabolic Pathways
Patent: 4,792,560 →
Application: 06/830,798 →
A Mandrel for Opening a Tube of Flexible Material
Patent: 4,693,059 →
Application: 06/835,042 →
Process for the Preparation of a Viscosity-Stable Antacid Composition
Patent: 4,744,986 →
Application: 06/837,527 →
Method for the Treatment of Pruritus and Composition for the Use Therein
Patent: 4,734,434 →
Application: 06/838,365 →
Aryl and Heteroaryl Ethers as Agents for the Treatment of Hypersensitive Alilments
Patent: 4,839,369 →
Application: 06/839,410 →
Aryl Pyrroles as Useful Antiallergy Compounds
Patent: 4,792,568 →
Application: 06/851,989 →
Bicyclic Benzenoid Aminoalkylene Ethers and Thioethers, Pharmaceutical Compositions and Use
Patent: 4,647,559 →
Application: 06/867,467 →
Amidinoureas for Treating Irritable Bowel Syndrome
Patent: 4,745,131 →
Application: 06/873,677 →
Pharmacological Dissolution Method and Apparatus
Patent: 4,856,909 →
Application: 06/877,146 →
Bicyclic Benzenoid Alkylene Amino Thieno(3,4-D)Isothiazole Ethers and Thioethers, Pharmaceutical Compositions and Use
Patent: 4,699,906 →
Application: 06/878,284 →
3- and 5-(3-(1-Arylureido))-1,2,4-Triazoles
Patent: 33,125 →
Application: 06/884,765 →
Pyridone-Pyridyl-Imidazolyl and Triazolyl Compounds and Their Use as Cardiotonic Agents
Patent: 4,743,608 →
Application: 06/885,895 →
Benzocyclobutene Aminoalkylene Ethers and Thioethers,Pharmaceutical Compositions and Use
Patent: 4,743,600 →
Application: 06/891,197 →
Phenoxyphenylacetates for Use as Potential Modulators of Arichidonic Acid Pathways
Patent: 4,748,272 →
Application: 06/891,846 →
Bicyclic Heteroaryl Thiazole Compounds, Cardiotonic Compositions Including the Same, and Their Uses
Patent: 4,818,755 →
Application: 06/897,064 →
Benzodiazinone-Pyridone Compounds, Cardiotonic Compositions Including the Same, and Their Uses
Patent: 4,764,512 →
Application: 06/900,868 →
Styryl Tetrazoles and Anti-Allergic Use Thereof
Patent: 4,868,193 →
Application: 06/911,028 →
Pyrido[2,3-D]Pyrimidinone and Imidazo[4,5-B]Pyrimidinone
Patent: 4,859,672 →
Application: 06/925,008 →
Bicyclic Benzenoid Aminoalkylene Ethers and Thioethers, Pharmaceutical Compositions and Use
Patent: 4,692,445 →
Application: 06/929,592 →
Bisarylamines
Patent: 4,795,757 →
Application: 06/932,557 →
Amide Analogs of Calcitonin
Patent: 4,804,742 →
Application: 06/938,671 →
Bicyclic Nitrogen Heterocyclic Ethers and Thioethers, and Their Pharmaceutical Uses
Patent: 4,847,264 →
Application: 06/945,669 →
Triamcinolone Acetonide for the Treatment of Allergic Rhinitis
Patent: 4,767,612 →
Application: 07/006,397 →
3-And 5-(Bicyclic Ether or Bicyclic Alkylene Thioether) Alkylene Amino Thiatriazines, and Their Pharmaceutical Uses
Patent: 4,727,169 →
Application: 07/010,900 →
Pyridyl-Pyridazinone and Pyridyl-Pyrazolinone Compounds and Their Use in the Treatment of Congestive Heart Failure
Patent: 4,826,835 →
Application: 07/011,490 →
Bicyclic Benzo-Oxy Heterocyclic Ethers and Thioethers Pharmaceutical Compositions and Use
Patent: 4,722,925 →
Application: 07/021,147 →
Pharmaceutical Tablet
Patent: 300,878 →
Application: 07/033,547 →
Des-19-Leucine, 20-Glutamine, 21-Threonine-Calcitonin
Patent: 4,764,590 →
Application: 07/040,963 →
Analogs of (1,7-Di-Alanine, Des-19-Leucine)
Patent: 4,820,804 →
Application: 07/040,964 →
Des-19-Leucine, 20-Glutamine, 21-Threonine, 22-Tyrosine-Calcitonin
Patent: 4,764,591 →
Application: 07/040,966 →
Pyridooxazinone-Pyridone Compounds, Cardiotonic Compositions Including the Same, and Their Uses
Patent: 4,822,794 →
Application: 07/047,394 →
Pyridooxazinone-Pyridazinone and Pyrazolone Compounds, Cardiotonic Compositions Including the Same, and Their Use
Patent: 4,829,066 →
Application: 07/047,395 →
(19-Alanine) Calcitonin
Patent: 4,824,936 →
Application: 07/047,798 →
(N-Alpha-Acyl,8-Glycine, Des-19-Leucine)-Calcitonin
Patent: 4,764,589 →
Application: 07/054,451 →
Spinnaker Sail for Kayaks, Canoes or Other Small Water Craft
Patent: 4,958,582 →
Application: 07/055,943 →
Bicyclic Benzenoid Aminoalkylene Ethers and Thioethers, Pharmaceutical Compositions and Use
Patent: 4,745,110 →
Application: 07/062,951 →
Benzodiazinone-Hydroxypyrazoly Compounds Cardiotonic Compositions Including the Same and Their Uses
Patent: 4,785,101 →
Application: 07/063,481 →
Purification of Von Willebrand Factor Solutions Using Gel Permeation Chromatography
Patent: 4,774,323 →
Application: 07/067,990 →
Imidazolylphenyl and 1,2,4-Triazolylphenyl Benzopyridazinone and Pyridopyridazinone Compounds and Their Use for Increasing Cardiotonic Contractility
Patent: 4,806,535 →
Application: 07/076,461 →
Benzodiazinone-Pyridazinone and Hydroxy-Pyrazolyl Compounds, Cardiotonic Compositions Including the Same, and Their Uses
Patent: 4,868,300 →
Application: 07/102,083 →
Bicyclic Benzonoid Alkylene Amino Thieno(3,4-D)Isothiazole Ethers and Thioethers, Pharmaceutical Compositions and Use
Patent: 4,748,164 →
Application: 07/104,849 →
Quinoline Derivatives and Use Thereof as Antagonists of Leukotriene D4
Patent: 4,920,132 →
Application: 07/116,420 →
Quinoline Derivatives and Use Thereof as Antagonists of Leukotriene D4
Patent: 4,920,133 →
Application: 07/116,428 →
Quinoline Derivatives and Use Thereof as Antagonists of Leukotriene D4
Patent: 4,920,130 →
Application: 07/116,597 →
Pharmaceutical Tablet
Patent: 300,673 →
Application: 07/118,838 →
Pharmaceutical Tablet
Patent: 300,264 →
Application: 07/118,839 →
Pharmaceutical Tablet
Patent: 301,763 →
Application: 07/121,772 →
Quinolinyl Ether or Thioether Tetrazoles as Agents for the Treatment of Hypersensitive Ailments
Patent: 4,874,769 →
Application: 07/124,800 →
Therapeutic Substituted Semicarbazides
Patent: 4,866,173 →
Application: 07/125,764 →
3- and 5-(Bicyclic Ether or Bicyclic Alkylene Thioether) Alkylene Amino Thiatriazines
Patent: 4,816,583 →
Application: 07/130,393 →
Pharmaceutical Tablet
Patent: 302,051 →
Application: 07/135,197 →
Novel Hmg-Coa Reductase Inhibitors
Patent: 4,863,957 →
Application: 07/135,805 →
Pharmaceutical Tablet
Patent: 304,626 →
Application: 07/136,155 →
Pharmaceutical Tablet
Patent: 301,764 →
Application: 07/136,156 →
Pharmaceutical Tablet
Patent: 301,765 →
Application: 07/136,157 →
Pharmaceutical Tablet
Patent: 301,766 →
Application: 07/138,884 →
Bicyclic Benzo-Oxy Heterocyclic Ethers and Thioethers, Pharmaceutical Compositions and Use
Patent: 4,777,168 →
Application: 07/142,084 →
Method of Prevention and Treatment of Peptic Ulcers
Patent: 4,831,040 →
Application: 07/150,808 →
Quinucilidyl Bezoxepins as 5-Ht, Antagonists
Patent: 4,857,517 →
Application: 07/152,112 →
Certain Benzoxepins and Their Pharmaceutical Compositions and Methods
Patent: 4,859,683 →
Application: 07/152,192 →
Stabilization of Multivitamin/Trace Elements Formulations
Patent: 4,804,535 →
Application: 07/153,182 →
Benzocyclobutene Aminoalkylene Ethers and Thioethers Pharmaceutical Composition and Use
Patent: 4,788,187 →
Application: 07/160,855 →
Process for the Preparation of a Viscosity-Stable Antacid Composition
Patent: 5,112,813 →
Application: 07/164,551 →
Dibenzofurancarboxamides and Their Pharmaceutical Compositions and Methods
Patent: 4,863,921 →
Application: 07/186,824 →
Antacid Composition
Patent: 4,869,902 →
Application: 07/191,836 →
Process for the Preparation of Crystalline Salts of Aryloxy- Propanolamines
Patent: 4,849,530 →
Application: 07/203,390 →
Method for the Preparation of a Theophylline Sustained Release Pharmaceutical Composition and the Composition Prepared Thereby
Patent: 5,026,709 →
Application: 07/203,435 →
Product-Dispensing Method and Apparatus
Patent: 4,876,891 →
Application: 07/203,566 →
Quinoline Derivatives and Use Thereof as Antagonists of Leukotriene D4
Patent: 4,920,131 →
Application: 07/209,428 →
Quinoline Derivatives and Use Thereof as Antagonists of Leukotriene D4
Patent: 4,918,081 →
Application: 07/210,468 →
Treatment of Conditions Requiring Enhanced Oxygen Availability to Mammalian Tissues
Patent: 4,861,795 →
Application: 07/211,486 →
Aryl and Heteroaryl Substituted Cycloalkyl Compounds
Patent: 4,843,081 →
Application: 07/213,043 →
Treatment of Conditions Requiring Enhanced Oxygen Availability to Mammalian Tissues
Patent: 4,849,416 →
Application: 07/223,585 →
Intranasal Calcitonin Formulations
Patent: 5,026,825 →
Application: 07/242,000 →
Anti-Acne Method and Composition
Application: 07/243,883 →
Method of Increasing Cardiac Contractility Using Pharmaceutical Compositions Comprisings Benzoiazinone- Pyridazinone or Hydroxy- Pyrazolyl Compounds
Patent: 4,906,630 →
Application: 07/255,664 →
Naphtheridinone- and Pyridooxazinone-Pyridone Compounds, Cardiotonic Compositions Including Same, and Their Uses
Patent: 4,866,074 →
Application: 07/255,728 →
Pyridazinone and Pyrazolone Compounds, Cardiotonic Compositions Including Same, and Their Uses
Patent: 4,906,629 →
Application: 07/255,749 →
Substituted Saturated and Unsaturated Indole Quinoline and Benzazepine Carboxamides and Their Use as Pharmacological Agents
Patent: 4,920,219 →
Application: 07/277,582 →
Heteroazabenzobicyclic Carboxamide 5-HT3 Antagonists
Patent: 4,933,445 →
Application: 07/277,610 →
Benzobicyclic Carboxamide 5-HT3 Antagonists
Patent: 4,920,227 →
Application: 07/277,611 →
Novel Hmg-Coa Reductase Inhibitors
Patent: 4,892,884 →
Application: 07/279,898 →
Hmg-Coa Reductase Inhibitors
Patent: 4,904,692 →
Application: 07/283,111 →
Transdermal Acrylic Multipolymer Drug Delivery System
Patent: 4,994,267 →
Application: 07/295,847 →
Pyridyl-Pyridazinone and Pyridyl-Pyrazolinone Compounds and Their Use in the Treatment of Congestive Heart Failure
Patent: 4,954,494 →
Application: 07/303,879 →
Calcitonin Suppository Formulations
Patent: 5,002,771 →
Application: 07/306,596 →
Product-Dispensing Method and Apparatus
Application: 07/335,426 →
Apparatus for Applying Wrappers
Patent: 4,944,829 →
Application: 07/338,117 →
Compounds Having Cardiotonic Activity
Patent: 5,002,944 →
Application: 07/350,366 →
Hexahydrodibenzofuran Carboxylic Acid Derivatives
Patent: 4,959,485 →
Application: 07/351,625 →
Benzoxepins as Intermediates of 5HT3 Antagonists
Patent: 4,924,010 →
Application: 07/351,685 →
High Recovery Process for Antihemophilic Factor
Patent: 4,977,246 →
Application: 07/361,885 →
Quinolinyl-Chromone Derivatives and Use for Treatment of Hypersensitive Ailments
Patent: 4,977,162 →
Application: 07/379,528 →
Treatment of Immobilized Matrices for Preparation of Pharmaceutical and Biological Products with Anti-Microbial Agents to Remove Pyrogen- Producing Organisms and Pyrogens
Application: 07/395,115 →
Novel Hmg-Coa Reductase Inhibitors
Patent: 4,992,429 →
Application: 07/398,015 →
Benzoxazine and Benzoxazepine Carboxamide 5-HT3 Antagonists
Patent: 4,935,511 →
Application: 07/412,768 →
Anti-Thrombotic Peptides and Pseudopeptides
Patent: 4,952,562 →
Application: 07/415,006 →
Anti-Thrombotic Peptides and Pseudopeptides
Patent: 5,051,405 →
Application: 07/419,305 →
Benzothiopyranyl Derivatives as Hmg-Coa Reductase Inhibitors
Patent: 4,946,860 →
Application: 07/431,417 →
Naphtheridinone- and Pyridooxazinone-Pyridone Compounds, Cardiotonic Compositions Including Same, and Their Uses
Patent: 5,015,638 →
Application: 07/432,070 →
Novel Arginine, Glycine, Aspartic Acid Derivatives as Platelet-Aggregation Inhibitors
Patent: 5,053,392 →
Application: 07/444,484 →
Hmg-Coa Reductase Inhibitors
Patent: 4,996,234 →
Application: 07/446,358 →
Quinoline Derivatives as Antagonists of Leukotriene D4
Patent: 5,051,427 →
Application: 07/449,957 →
Hmg-Coa Reductase Inhibitors
Patent: 4,994,494 →
Application: 07/450,493 →
Hmg-Coa Reductase Inhibitors
Patent: 5,001,128 →
Application: 07/451,407 →
Aryl-Substituted Benzocycloalkyl-Derived Anti-Atherosclerotic Agents
Patent: 5,114,964 →
Application: 07/461,198 →
Quinoline Derivatives and Their Use as Antagonists of Leukotriene D4
Patent: 5,059,610 →
Application: 07/477,896 →
Treatment of Conditions Requiring Enhanced Oxygen Availability to Mammalian Tissues
Patent: 5,015,663 →
Application: 07/488,190 →
Substituted Saturated and Unsaturated Indole Quinoline and Benzazepine Carboxamides and Their Use as Pharmacological Agents
Patent: 5,063,230 →
Application: 07/489,646 →
Anti-Thrombotic Peptide and Pseudopeptide Derivatives
Patent: 5,064,814 →
Application: 07/505,286 →
Styryl-Substituted Monocyclic and Bicyclic Heteroaryl Compounds Which Inhibit Egf Receptor Tyrosine Kinase
Application: 07/509,942 →
Heterocyclicethenediyl Compounds Which Inhibit Egf Receptor Tyrosine Kinase
Application: 07/509,981 →
Substituted Cyclohexene Derivatives as Hmg-Coa Reductase Inhibitors
Patent: 5,001,144 →
Application: 07/510,351 →
Styryl Compounds Which Inhibit Egf Receptor Protein Tyrosine Kinase
Application: 07/515,602 →
Quinolinyl-Benzoheterobicyclic Derivatives as Antagonists of Leukotriene D4
Patent: 5,041,453 →
Application: 07/532,464 →
Anti-Thrombotic Peptides and Pseudopeptides
Application: 07/534,385 →
A Method for Suturing with a Bioabsorbable Needle
Patent: 4,981,149 →
Application: 07/534,495 →
Tetrahydro-Pyrido-Indoles as Cholecystokinin and Gastrin Antagonists
Application: 07/542,495 →
Tetrahydro-Pyrido-Indoles as Cholecystokinin and Gastrin Antagonists
Patent: 5,162,336 →
Application: 07/573,514 →
Related Assignments (24)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest. Aug 28, 1980
From: HUGHES, JOHN L.,; LIU, ROBERT C.; SEYLER, JAY K.
To: ARMOUR PHARMACEUTICAL COMPANY, A CORP. OF DE
Reel/Frame 003812/0586 →
Assignment of Assignors Interest. Sep 22, 1980
From: ORLOWSKI, RONALD C.; GROGINSKY, CHARLES M.; SEYLER, JAY K.
To: ARMOUR PHARMACEUTICAL COMPANY
Reel/Frame 003818/0076 →
Assignment of Assignors Interest. Mar 3, 1981
From: ARMOUR AND COMPANY
To: ARMOUR PHARMACEUTICAL COMPANY
Reel/Frame 003830/0193 →
Assignment of Assignors Interest. Jun 1, 1981
From: YOUSSEFYEH, RAYMOND D.; JONES, HOWARD
To: USV PHARMACEUTICAL CORPORATION, A CORP. OF DE.
Reel/Frame 003926/0206 →
Assignment of Assignors Interest. Jul 30, 1981
From: KAISER, EMIL; COLESCOTT, ROBERT L.
To: ARMOUR PHARMACEUTICAL COMPANY
Reel/Frame 003885/0410 →
Assignment of Assignors Interest. Oct 29, 1981
From: SUH, JOHN T.; SKILES, JERRY W.; WILLIAMS, BRUCE E.
To: USV PHARMACEUTICAL CORPORATION
Reel/Frame 003920/0901 →
Assignment of Assignors Interest. Feb 12, 1982
From: ORLOWSKI, RONALD C.; SEYLER, JAY K.
To: ARMOUR PHARMACEUTICAL COMPANY, A CORP. OF DE
Reel/Frame 003993/0717 →
Assignment of Assignors Interest. Feb 12, 1982
From: ORLOWSKI, RONALD C.; SEYLER, JAY K.
To: ARMOUR PHARMACEUTICAL COMPANY, A CORP. OF DE
Reel/Frame 003977/0394 →
Assignment of Assignors Interest. Feb 12, 1982
From: ORLOWSKI, RONALD C.; SEYLER, JAY K.
To: ARMOUR PHARMACEUTICAL COMPANY, A CORP. OF DE
Reel/Frame 003977/0395 →
Assignment of Assignors Interest. Feb 12, 1982
From: ORLOWSKI, RONALD C.; SEYLER, JAY K.
To: ARMOUR PHARMACEUTICAL COMPANY
Reel/Frame 003993/0716 →
Assignment of Assignors Interest. May 19, 1982
From: ORLOWSKI, RONALD C.; GROGINSKY, CHARLES M.; SEYLER, JAY K.
To: ARMOUR PHARMACEUTICAL COMPANY, KANKAKEE, ILL. A CORP. OF DE.
Reel/Frame 004002/0591 →
Assignment of Assignors Interest. Sep 24, 1982
From: ORLOWSKI, RONALD C.; SEYLER, JAY K.
To: ARMOUR PHARMACEUTICAL COMPANY A CORP OF DE
Reel/Frame 004055/0110 →
Assignment of Assignors Interest. Sep 24, 1982
From: STAHL, GLENN L.; ORLOWSKI, RONALD C.
To: ARMOUR PHARMACEUTICAL COMPANY, A CORP. OF DE
Reel/Frame 004048/0529 →
Assignment of Assignors Interest. Nov 8, 1982
From: ORLOWSKI, RONALD C.; SEYLER, JAY K.
To: ARMOUR PHARMACEUTICAL COMPANY
Reel/Frame 004069/0044 →
Assignment of Assignors Interest. Feb 14, 1983
From: YOUSSEFYEH, RAYMOND D.; SKILES, JERRY W.; SUH, JOHN T.; JONES, HOWARD
To: USV PHARMACEUTICAL CORPORATION
Reel/Frame 004121/0437 →
Assignment of Assignors Interest. Mar 4, 1983
From: ORLOWSKI, RONALD C.; SEYLER, JAY K.
To: ARMOUR PHARMACEUTICAL COMPANY A CORP OF DE.
Reel/Frame 004103/0990 →
Assignment of Assignors Interest. Apr 4, 1983
From: ORLOWSKI, RONALD C.; SEYLER, JAY K.
To: ARMOUR PHARMACEUTICAL COMPANY
Reel/Frame 004114/0282 →
Assignment of Assignors Interest. Apr 4, 1983
From: ORLOWSKI, RONALD C.; SEYLER, JAY K.
To: ARMOUR PHARMACEUTICAL COMPANY
Reel/Frame 004114/0205 →
Assignment of Assignors Interest. Feb 2, 1984
From: DOUGLAS, GEORGE H.; STUDT, WILLIAM L.; DODSON, STUART A.; ZIMMERMAN, HARRY K.
To: WILLIAM H. RORER, INC.
Reel/Frame 004216/0833 →
Assignment of Assignors Interest. Mar 7, 1988
From: ARMOUR & PHARMACEUTICAL COMPANY A DE CORP.
To: RORER PHARMACEUTICAL CORPORATION, A CORP. OF DE
Reel/Frame 004836/0859 →
Assignment of Assignors Interest. Jul 11, 1988
From: CHEMIE HOLDING AKTIENGESELLSCHAFT
To: RORER PHARMACEUTICAL CORPORATION, 500 VIRGINIA DRIVE, FORT WASHINGTON, PA 19034, A CORP. OF DE.
Reel/Frame 004918/0327 →
Assignment of Assignors Interest. Dec 20, 1990
From: RHONE-POULENC RORER PHARMACEUTICALS INC.
To: TAKEDA CHEMICAL INDUSTRIES, LTD.
Reel/Frame 005544/0122 →
Assignment of Assignor's Interest Apr 18, 1994
From: RHONE-POULENC RORER PHARMACEUTICALS INC.
To: RHONE-POULENC RORER PHARMACEUTICAL PRODUCTS INC.
Reel/Frame 006945/0770 →
Corrective Assignment to Correct Assignee's Name an Assignment Was Previously Recorded at Reel 6945, Frames 770-772. Jun 10, 1994
From: RHONE-POULENC RORER PHARMACEUTICALS INC.
To: ARMOUR PHARMACEUTICAL PRODUCTS INC.
Reel/Frame 007015/0067 →